Inactive Instrument

Calendar Intrexon Corp Nyse

Equities

US46122T1025

Chart calendar Intrexon Corp

1.QPNGS0CO5dib0vqzA9YyCBxlefKpKyUs8bBGcayT6ZU.dJgIJ3TEve_Ut5_pdqxkRHAPILHdfX9Ng4kiN8j0h9MspD85DL-jleG7iQ~ad05daf64d7ec1decaaf5a85438fead8

Upcoming events on Intrexon Corp

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-02-25 Q4 2024 Earnings Release (Projected)

Past events on Intrexon Corp

2024-03-25 01:00 pm Investor Meeting - Cantor Fitzgerald
2024-03-19 04:30 pm Q4 2023 Earnings Call
2024-03-19 04:05 pm Q4 2023 Earnings Release
2024-02-13 03:20 pm Oppenheimer Healthcare Life Sciences Conference
2024-01-10 08:15 pm JPMorgan Healthcare Conference
2023-12-06 03:00 pm JMP Securities Hematology and Oncology Summit
2023-11-15 10:55 am Stifel Healthcare Conference
2023-11-09 04:55 pm Q3 2023 Earnings Release
2023-10-26 02:00 pm Cantor AML Virtual Conference - Panel
2023-10-11 06:30 pm Cell & Gene Meeting on the Mesa Conference
2023-09-26 04:55 pm Cantor Global Healthcare Conference
2023-08-09 08:30 am Q2 2023 Earnings Call
2023-08-09 08:00 am Q2 2023 Earnings Release
2023-06-08 09:00 am Annual General Meeting
2023-06-07 03:15 pm BIO International Convention
2023-06-05 02:15 pm American Society of Clinical Oncology Conference - Abstract #5590
2023-06-03 09:00 am American Society of Clinical Oncology Conference - Abstract #2628
2023-05-10 08:00 am Q1 2023 Earnings Call
2023-05-10 08:00 am Q1 2023 Earnings Release
2023-04-17 09:00 am American Association for Cancer Research Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
90,7
106
-14.2%
103
104
-1.07%
104
102
1.86%
26,9
57,9
-53.5%
6,23
6,64
-6.23%

5,59

EBITDA
Million USD
Released
Forecast
Spread
-149
-154
3.57%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-173
-181
3.94%
-85,7
-117
26.69%
-78,8
-81,8
3.65%
-75,7
-68,4
-10.75%
-99,8
-85,3
-16.97%

-90,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-209
-196
-6.37%
-104
-133
21.67%
-96,9
-98,1
1.23%
-80,0
-72,3
-10.55%
-96,4
-82,4
-16.99%

-89,9

Net income
Million USD
Released
Forecast
Spread
-322
-195
-64.94%
-171
-139
-22.91%
-92,2
-95,8
3.76%
28,3
-24,8
214.05%
-95,9
-82,5
-16.26%

-89,6

EPS
USD
Released
Forecast
Spread
-2,09
-1,27
-64.73%
-1,02
-0,86
-18.2%
-0,47
-0,49
3.8%
0,14
0,14
0%
-0,39
-0,36
-9.29%

-0,34

Announcement Date02/03/2001/03/2101/03/2206/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
24,2
22,2
8.89%
32,0
23,3
37.63%
2,91
22,5
-87.08%
16,7
35,3
-52.65%
1,76
6,21
-71.61%
1,85
2,97
-37.61%
1,77
2,18
-18.94%
1,38
1,98
-30.18%
1,23
1,70
-27.76%

1,48


1,48


1,48


1,48


16,8

EBIT
Million USD
Released
Forecast
Spread
-20,5
-22,8
10.04%
-17,4
-21,9
20.48%
-24,2
-27,0
10.39%
-7,61
-24,2
68.56%
-21,8
-18,7
-16.44%
-23,5
-23,5
-0.12%
-21,1
-24,4
13.48%
-20,9
-19,0
-9.92%
-34,2
-19,9
-71.96%

-22,4


-22,6


-22,9


-23,2




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,0
-26,2
4.67%
-19,3
-26,4
26.86%
-26,1
-29,7
11.95%
-7,69
-27,7
72.22%
-22,2
-19,2
-15.34%
-22,8
-23,7
3.84%
-20,4
-24,4
16.58%
-19,8
-18,9
-4.85%
-33,4
-19,2
-73.58%

-22,1


-22,3


-22,7


-23,0




Net income
Million USD
Released
Forecast
Spread
-25,0
-26,2
4.63%
-19,3
-26,4
27.08%
-17,6
-29,7
40.62%
87,4
-27,7
415.47%
-22,2
-19,2
-15.38%
-22,7
-23,7
4.08%
-20,3
-24,4
16.84%
-19,8
-18,9
-4.81%
-33,1
-19,2
-71.85%

-22,1


-22,3


-22,7


-23,0




EPS
USD
Released
Forecast
Spread
-0,13
-0,14
4.66%
-0,10
-0,13
21.57%
-0,09
-0,15
37.93%
0,44
-0,14
425.93%
-0,11
-0,10
-10%
-0,10
-0,10
3.22%
-0,08
-0,10
20.41%
-0,08
-0,08
-3.24%
-0,13
-0,08
-68.83%

-0,09


-0,08


-0,08


-0,08


-0,05

Announcement Date01/03/2209/05/2208/08/2209/11/2206/03/2310/05/2309/08/2309/11/2319/03/24-----